Baoxin Du
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 25, 2026
Semen Strychni Pulveratum and vomicine alleviate neuroinflammation in amyotrophic lateral sclerosis through cGAS-STING-TBK1 pathway.
Journal: Journal of ethnopharmacology
Published: April 24, 2024
Ginsenoside-Rg1 combined with a conditioned medium from induced neuron-like hUCMSCs alleviated the apoptosis in a cell model of ALS through regulating the NF-κB/Bcl-2 pathway.
Journal: Chinese journal of natural medicines
Published: February 06, 2023
Prevalence of multiple sclerosis in Guangzhou, China: A population-based case-finding prospective study.
Journal: Multiple sclerosis and related disorders
Published: May 25, 2022
Fertility Does Not Alter Disease Progression in ALS Patients of Childbearing Age: A Three Centers Retrospective Analysis in Southern China.
Journal: Frontiers in neurology
Published: March 13, 2022
Painful Diabetic Peripheral Neuropathy Study of Chinese Outpatients (PDNSCOPE): A Multicentre Cross-Sectional Registry Study of Clinical Characteristics and Treatment in Mainland China.
Journal: Pain and therapy
Published: May 03, 2021
Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 07, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026